^
    BIOMARKER:

    HER-2 overexpression

    i
    Other names: ERBB2, CD340, HER-2, HER2, NEU, NGL, V-erb-b2 avian erythroblastic leukemia viral oncogene homolog 2




    Show legend

    Include preclinical:
    Breast Cancer
    HER2 Positive Breast Cancer
    Gastric Cancer
    Gastroesophageal Junction Adenocarcinoma
    Hormone Receptor Positive Breast Cancer
    Solid Tumor
    Gastric Adenocarcinoma
    Endometrial Cancer
    Urothelial Cancer
    Salivary Gland Cancer
    Esophageal Adenocarcinoma
    Gastroesophageal Cancer
    Colorectal Cancer
    Hormone Receptor Negative Breast Cancer
    Esophageal Cancer
    Pancreatic Cancer
    Non Small Cell Lung Cancer
    Ovarian Cancer
    Uterine Cancer
    Bladder Cancer
    Biliary Tract Cancer
    Cholangiocarcinoma
    Lung Adenocarcinoma
    Endometrial Adenocarcinoma
    Gallbladder Cancer
    Cervical Cancer
    Estrogen Receptor Positive Breast Cancer
    trastuzumab
    pembrolizumab + trastuzumab
    trastuzumab + pertuzumab
    fam-trastuzumab deruxtecan-nxki
    ado-trastuzumab emtansine
    lapatinib
    trastuzumab-dttb
    trastuzumab-anns
    trastuzumab-dkst
    trastuzumab-qyyp
    trastuzumab-pkrb
    ZW25
    neratinib
    BNT323
    disitamab vedotin
    Zercepac (trastuzumab biosimilar)
    Her-VAXX
    trastuzumab + lapatinib
    BI 1810631
    CT-0508
    AT101
    cabazitaxel
    trastuzumab/hyaluronidase-oysk
    poziotinib
    trastuzumab + MCLA-128
    nivolumab + fam-trastuzumab deruxtecan-nxki
    ASLAN001
    KN046 + KN026
    cetuximab
    HLX22
    IKS014
    eribulin mesylate
    KN026
    pembrolizumab
    olaparib + neratinib
    trastuzumab + MM-302
    olaparib + niraparib + trastuzumab duocarmazine
    brusatol
    DHES0815A
    pertuzumab + ado-trastuzumab emtansine
    ribociclib
    neratinib + IRX4204
    tucatinib + IRX4204
    trastuzumab + IRX4204
    IRX4204
    THAL-SNS-032
    fam-trastuzumab deruxtecan-nxki + AZD1775
    EGFR inhibitor
    HER2 inhibitor
    TCHP
    T-lymphocyte cell therapy